Selection of vasodilator, inotropic or combined therapy for the management of heart failure.

[1]  J. Cohn,et al.  Comparative haemodynamic and metabolic effects of vasodilator and inotropic agents in experimental myocardial infarction. , 1978, Cardiovascular research.

[2]  J. Cohn,et al.  Ephedrine-nitroprusside combination in congestive heart failure , 1978 .

[3]  B. Massie,et al.  Hemodynamic advantage of combined administration of hydralazine orally and nitrates nonparenterally in the vasodilator therapy of chronic heart failure. , 1977, The American journal of cardiology.

[4]  J. Cohn,et al.  Comparative Hemodynamic Effects of Inotropic and Vasodilator Drugs in Severe Heart Failure , 1977, Circulation.

[5]  G. Todd,et al.  The effect of dobutamine on cardiac oxygen balance, regional blood flow, and infarction severity after coronary artery narrowing in dogs. , 1977, Circulation research.

[6]  R. Miller,et al.  Sustained reduction of cardiac impedance and preload in congestive heart failure with the antihypertensive vasodilator prazosin. , 1977, The New England journal of medicine.

[7]  R. Miller,et al.  Reduction of S-T segment elevation with infusion of nitroprusside in patients with acute myocardial infarction. , 1976, The American journal of cardiology.

[8]  R. C. Reeves,et al.  Factors influencing left ventricular shortening in isolated canine heart. , 1976, The American journal of physiology.

[9]  J. Tyberg,et al.  Hemodynamic and Metabolic Effects of Sodium Nitroprusside on the Performance and Metabolism of Regional Ischemic Myocardium , 1975, Circulation.

[10]  J. Cohn,et al.  Hemodynamic effect of dobutamine in patients with severe heart failure. , 1975, The American journal of cardiology.

[11]  J. Cohn,et al.  TREATMENT OF REFRACTORY HEART FAILURE WITH INFUSION OF NITROPRUSSIDE , 1975 .

[12]  D. Harrison,et al.  Circulatory effects of tazolol in experimental myocardial infarction. , 1975, The American journal of cardiology.

[13]  R. Tuttle,et al.  Dobutamine: DEVELOPMENT OF A NEW CATECHOLAMINE TO SELECTIVELY INCREASE CARDIAC CONTRACTILITY , 1975, Circulation research.

[14]  J. A. Snow,et al.  Chronic vasodilator therapy in the management of cardiogenic shock and intractable left ventricular failure. , 1974, Annals of internal medicine.

[15]  E. Braunwald,et al.  Effects of dobutamine on left ventricular performance, coronary dynamics, and distribution of cardiac output in conscious dogs. , 1974, The Journal of clinical investigation.

[16]  W. Parmley,et al.  Hemodynamic and Metabolic Responses to Vasodilator Therapy in Acute Myocardial Infarction , 1973, Circulation.

[17]  W. Parmley,et al.  Beneficial Effects of Vasodilator Agents in Severe Mitral Regurgitation Due to Dysfunction of Subvalvar Apparatus , 1973, Circulation.

[18]  J. Cohn,et al.  Positive inotropic effect of oral esproquin in normal subjects , 1973, Clinical pharmacology and therapeutics.

[19]  J. Cohn,et al.  Inotropic properties of an isoquinoline derivative (NC 7197) in man , 1973 .

[20]  Oxon Ma.  Gerald Legh Malins McElligott. , 1972 .

[21]  J. Cohn,et al.  IMPROVED LEFT VENTRICULAR FUNCTION DURING NITROPRUSSIDE INFUSION IN ACUTE MYOCARDIAL INFARCTION , 1972 .

[22]  L. I. Goldberg,et al.  Cardiovascular and renal actions of dopamine: potential clinical applications. , 1972, Pharmacological reviews.

[23]  W. Kannel,et al.  The natural history of congestive heart failure: the Framingham study. , 1971, The New England journal of medicine.

[24]  D. Littmann.  The natural history of congestive heart failure. , 1971, The New England journal of medicine.

[25]  S. Taylor,et al.  Phentolamine for vasodilator treatment of severe heart-failure. , 1971, Lancet.

[26]  E. Sonnenblick,et al.  Myocardial energetics: basic principles and clinical implications. , 1971, The New England journal of medicine.

[27]  F. Tristani,et al.  Cardiac and peripheral vascular effects of digitalis in clinical cardiogenic shock. , 1969, American heart journal.

[28]  J. Cohn,et al.  Blood pressure measurement in shock. Mechanism of inaccuracy in ausculatory and palpatory methods. , 1967, JAMA.

[29]  J. McNay,et al.  Dopamine in the treatment of hypotension and shock. , 1966, The New England journal of medicine.

[30]  J. Cohn.  Comparative Cardiovascular Effects of Tyramine, Ephedrine, and Norepinephrine in Man , 1965, Circulation research.

[31]  Harold T. Dodge,et al.  Left Ventricular Tension and Stress in Man , 1963, Circulation research.

[32]  W. Black,et al.  Value of prolonged bed rest in management of cardiomegaly. , 1963, JAMA.

[33]  J. P. Gilmore,et al.  Homeometric Autoregulation in the Heart , 1960, Circulation research.

[34]  M. Rand,et al.  The action of sympathomimetic amines in animals treated with reserpine , 1958, The Journal of physiology.

[35]  H. Barcroft,et al.  On the actions of noradrenaline, adrenaline and isopropyl noradrenaline on the arterial blood pressure, heart rate and muscle blood flow in man , 1949, The Journal of physiology.

[36]  D. Greene,et al.  The hemodynamic response of man to nor-epinephrine and epinephrine and its relation to the problem of hypertension. , 1948, The American journal of medicine.

[37]  J. Cohn,et al.  Combined oral hydralazine-nitrate therapy in left ventricular failure. Hemodynamic equivalency to sodium nitroprusside. , 1978, Chest.

[38]  J. Cohn,et al.  Inotropism without chronotropism in response to isoproterenol after combined beta and alpha adrenergic blockade in man , 1976 .